window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-113618785-13');


Read all about the PORSAV project

1907, 2021

Palliare obtains regulatory approvals in Ireland for PORSAV innovative devices

July 19th, 2021|

A major milestone in the project has been achieved, paving the way for the initiation of the PORSAV clinical investigation in Ireland. Left: EndoTrap™ mask/sleeve system for protection of endoscopist.  Centre: LeakTrap™ collector rings (black rings touching patient skin and top of trocar) Right: vacuum system. Palliare's devices EndoTrap and LeakTrap have received ethical approval from both the newly-formed National Office for Research Ethics Committees (NREC) for Medical Devices and Competent Authority clearance from the Health Products Regulatory Authority (HPRA). The National Office for Research Ethics Committee for Medical Devices launched in May 2021 and the PORSAV approval is the first trial to be approved by it. NREC ensures that Ireland is an attractive place to conduct research in these important areas and maximise the opportunity for Irish patients to participate in forefront research, gaining access to innovative medicines and services.

807, 2021


July 8th, 2021|

Dusty Rhodes of the Camfil Group based in the UK  goes into the heart of a hospital to find out about PORSAV and clean air in the operating theatre. Hear how Dublin city’s leading hospital and university collaborated on a new piece of research that photographed air flows around the patient and doctors and how they went about reducing the effects of aerosols. Listen to the "Let's Talk Clean Air" episode 10 podcast interview with Prof. Ronan Cahill and Dr Kevin Nolan of University College Dublin here. Read the transcript here.  

107, 2021

PORSAV partner Palliare raises €6.7 million in an oversubscribed series A funding round

July 1st, 2021|

PORSAV scientific leaders Palliare Limited, an emerging company with the vision to create a safer operating room,  announced the closing of an oversubscribed $8 million Series A funding round. The funds will be used to support US commercial launch activities related to Palliare’s EVA15 insufflator and smoke evacuation system, as well as new Research & Development activities, including PORSAV outputs. There has been growing awareness of the hazardous nature of surgical smoke to the operating room staff, and various medical organizations in the USA have been lobbying for the safe evacuation of all surgical smoke. The COVID-19 pandemic further heightened awareness across the clinical community of the exposure of medical staff to aerosolized viruses in the operating room. In 2021 alone, nine (9) US states have introduced smoke evacuation bills, and more are anticipated in the coming months. Read the full announcement in the press release here.

1006, 2021

PI John O’Dea Palliare will take PORSAV innovations on the road

June 10th, 2021|

Palliare Limited CEO John O'Dea is planning an autumn roadshow in the US to promote PORSAV-enhanced innovations the Leak-Trap and Endo-Trap, as well as their EVA15 product. John plans to attend the AORN Global Surgical Conference & Expo in Orlando, Florida, from August 7th- 10th, 2021. The Palliare roadshow continues at SAGES 2021 to be held in Las Vegas, Nevada from August 31st - September 3rd, 2021. Finally, as an American Foregut Society Annual Meeting delegate, John will head to Nashville, Tennesee, September 23rd- 26th, 2021.

2505, 2021

Welcome to the PORSAV team, Caroline Crowley

May 25th, 2021|

We extend a warm welcome to Caroline Crowley, a new PORSAV team member at the University College Dublin (UCD). Danielle Nicholson at Pintail Limited asked Caroline for a brief interview to welcome her to the project. Where did you complete your degree and what did you study? Caroline Crowley I completed both my undergraduate and Masters degrees in Mechanical Engineering in UCD. Tell me about your Masters- what was the title of your thesis? The title of my thesis was " A CFD simulation of aerosol generating high flow nasal oxygen therapy for critical Covid-19 patients and development of mitigation strategies". The project involved investigating exhalation jets from the nose and mouth produced by patients receiving HFNO (High-flow nasal oxygen) therapy. I used schlieren imaging to visualize the jets experimentally and created a computational fluid dynamics (CFD) model to further investigate how HFNO affects aerosol dispersion in the exhaled air. Where did you complete this work? The experimental component of the work was completed at the Mater Hospital in Dublin. I mainly worked remotely for the simulation component of the project. ...

Go to Top